High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling

High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling

Background. Preoperative chemoradiotherapy (pCRT) is a common and essential therapeutic strategy for patients with locally advanced rectal cancer (LARC), but poor tumor response and therapeutic resistance to chemoradiotherapy have appeared usually among persons and affected those patients’ survival...

Full description

Bibliographic Details
Main Authors:	Hao Liu, Zhenzhan Zhang, Peilin Zhen, Meijuan Zhou
Format:	Article
Language:	English
Published:	Hindawi Limited 2021-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2021/6657012

Similar Items

The semantic and orthographic contribution to VSTM: Evidence from behavioral and neuroimaging experiments
by: Hsi-yi Chen, et al.
Published: (2007)

Differential effects of N-linked glycosylation of Vstm5 at multiple sites on surface expression and filopodia formation.
by: A-Ram Lee, et al.
Published: (2017-01-01)

Metacognition of visual short-term memory: Dissociation between objective and subjective components of VSTM
by: Silvia eBona, et al.
Published: (2013-02-01)

ADJUVANT CHEMOTHERAPY AFTER RECTAL CANCER CHEMORADIOTHERAPY
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01)

Post-chemoradiotherapy adjuvant chemotherapy of rectal cancer
by: E. V. Ledin, et al.
Published: (2018-08-01)

Oral fluorpyrimidines in preoperative chemoradiotherapy for operable rectal cancer
by: Yu. A. Barsukov, et al.
Published: (2016-01-01)

BIOLOGICAL MARKERS OF RECTAL CANCER NEOADJUVANT CHEMORADIOTHERAPY EFFICACY
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01)

Neoadjuvant chemoradiotherapy in combined treatment of patients with rectal cancer
by: N. A. Maistrenko, et al.
Published: (2017-08-01)

Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer
by: Oh Jae Hwan, et al.
Published: (2011-05-01)

A review of preoperative chemoradiotherapy for lower rectal cancer
by: Naohito Beppu, et al.
Published: (2017-07-01)

Expression of VSTM1-v2 Is Increased in Peripheral Blood Mononuclear Cells from Patients with Rheumatoid Arthritis and Is Correlated with Disease Activity.
by: Dashan Wang, et al.
Published: (2016-01-01)

Identification et caractérisation de VSTM2A comme un nouveau facteur modulant l'adipogenèse
by: Secco, Blandine
Published: (2017)

Systemic inflammatory markers as predictors of response to chemoradiotherapy in rectal cancer
by: S. Seber, et al.
Published: (2020-10-01)

Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Kazushige Kawai, et al.
Published: (2017-04-01)

Preoperative Chemoradiotherapy in Elderly Patients with Locally Advanced Rectal Cancer
by: Francesca De Felice, et al.
Published: (2013-01-01)

Predictive immunohistochemical features for tumour response to chemoradiotherapy in rectal cancer
by: E. Shinto, et al.
Published: (2020-04-01)

Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy
by: Hui-Ching Wang, et al.
Published: (2019-08-01)

HLA class I expression and its alteration by preoperative hyperthermo-chemoradiotherapy in patients with rectal cancer.
by: Hiro Sato, et al.
Published: (2014-01-01)

The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
by: J. Martinez-Useros, et al.
Published: (2018-02-01)

P2-18: Temporal and Featural Separation of Memory Items Play Little Role for VSTM-Based Change Detection
by: Dae-Gyu Kim, et al.
Published: (2012-10-01)

A functional SNP associated with atopic dermatitis controls cell type-specific methylation of the VSTM1 gene locus
by: Dilip Kumar, et al.
Published: (2017-02-01)

Hypermethylation and Downregulation of UTP6 Are Associated With Stemness Properties, Chemoradiotherapy Resistance, and Prognosis in Rectal Cancer: A Co-expression Network Analysis
by: Yiyi Zhang, et al.
Published: (2021-08-01)

Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy
by: Yaqi Wang, et al.
Published: (2019-04-01)

Prognostic Value of the FOXK Family Expression in Patients with Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy
by: Zhang Y, et al.
Published: (2020-09-01)

MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
by: Svoboda Marek, et al.
Published: (2012-11-01)

Validation of Gene Expression-Based Predictive Biomarkers for Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
by: Tomoyuki Momma, et al.
Published: (2021-09-01)

2-CONSERVATIVE TREATMENT OF RECTAL ADENOCARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY, IS IT ACCEPTABLE?
by: Majeed H Alwan
Published: (2009-06-01)

Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Ming‐Yii Huang, et al.
Published: (2020-03-01)

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
by: Molinari Chiara, et al.
Published: (2011-11-01)

Knowledge, Attitudes, and Practices Related to Preoperative Chemoradiotherapy in Rectal Cancer Patients
by: Xingxing Chen, et al.
Published: (2016-01-01)

Complete response after chemoradiotherapy for rectal cancer: what is the reasonable approach?
by: Rödel Claus, et al.
Published: (2017-12-01)

Personalised medicine in rectal cancer : understanding and predicting response to neoadjuvant chemoradiotherapy
by: Alderdice, Matthew
Published: (2017)

The prognostic role of extramural venous invasion in post-chemoradiotherapy rectal cancer
by: Chand, Manish
Published: (2015)

Automated Prediction of the Response to Neoadjuvant Chemoradiotherapy in Patients Affected by Rectal Cancer
by: Castellani, G., et al.
Published: (2022)

To investigate the downstream signaling change induced by the IL-6 glycoforms
by: Kuan-HsienLan, et al.
Published: (2017)

Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
by: Jian Wang, et al.
Published: (2021-07-01)

Serum Apolipoprotein A-I Predicts Response of Rectal Cancer to Neoadjuvant Chemoradiotherapy
by: Guo S, et al.
Published: (2021-03-01)

Potential of miR-21 to Predict Incomplete Response to Chemoradiotherapy in Rectal Adenocarcinoma
by: Susana Ourô, et al.
Published: (2020-10-01)

Genomic and Transcriptomic Characterisation of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
by: Sinead Toomey, et al.
Published: (2020-07-01)

Optimal time intervals between preoperative radiotherapy or chemoradiotherapy and surgery in rectal cancer?
by: Bengt eGlimelius
Published: (2014-04-01)

Cannot write session to /tmp/vufind_sessions/sess_pr6ofrtn4all2n19es75va3aj9